Metastatic Colon Carcinoma

8 clinical trials · Condition

Record	Firm	Date
Microbiotic Product to Promote Microbiome Health and Improve Chemotherapy Delivery (NCT05296681)	Howard S. Hochster, MD	2022-05-03
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial (NCT04704661)	National Cancer Institute (NCI)	2021-08-09
Enhanced Outpatient Symptom Management to Reduce Acute Care Visits Due to Chemotherapy-Related Adverse Events (NCT05038254)	M.D. Anderson Cancer Center	2021-05-12
18F-FMAU PET/CT and MRI for the Detection of Brain Tumors in Patients With Brain Cancer or Brain Metastases (NCT04752267)	University of Southern California	2021-02-15
Perioperative MVT-5873, a Fully Human Monoclonal Antibody Against a CA 19-9 Epitope, for Operable CA 19-9 Producing Pancreatic Cancers, Cholangiocarcinomas, and Metastatic Colorectal Cancers (NCT03801915)	National Cancer Institute (NCI)	2019-11-13
Trametinib and Trifluridine and Tipiracil Hydrochloride in Treating Patients With Colon or Rectal Cancer That is Advanced, Metastatic, or Cannot Be Removed by Surgery (NCT03317119)	City of Hope Medical Center	2018-04-11

Every clearance here is in the API, with alerts when new ones post.